Alabama Medical Cannabis Sales Gear for Spring 2026 Launch

Alabama’s medical cannabis program aims to begin retail sales in spring 2026, affecting clinicians’ ability to recommend cannabis products to eligible patients in the state.

Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds

Cannabis cannabinoids CBD and CBG show potential therapeutic effects against hepatic steatosis, offering clinicians evidence-based rationale for investigating these compounds in fatty liver disease management protocols.

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …

This article examines regulatory enforcement actions against cannabis beverage companies, highlighting compliance challenges clinicians should understand when advising patients on product safety and legality.

New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …

New Top Cannabis Regulator Sets Priorities In First Board Meeting

A newly appointed cannabis regulator outlined priorities at their initial board meeting, establishing policy direction relevant to clinical practice and patient care standards.

Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

Brazil’s evolving cannabis regulations and their clinical implications for medical practitioners operating within the country’s changing legal framework.

2 Greater Cincinnati breweries file lawsuit over Ohio ban on THC beverages – WLWT

Two Ohio breweries are legally challenging the state’s prohibition on THC-containing beverages, a regulatory issue affecting cannabis product availability and formulation standards in the beverage market.

New Ohio law means THC-infused drinks won’t be available on many store shelves – WTVG

Ohio’s new law restricts THC-infused beverage distribution in retail settings, limiting patient access routes and requiring clinicians to understand evolving product availability for treatment recommendations.

Lawmakers strike down bill capping THC levels in Oregon’s cannabis edibles – Yahoo

Oregon lawmakers rejected legislation that would have limited THC concentrations in cannabis edibles, affecting dosing standardization and clinical product consistency for medical cannabis patients.

Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and … – PubMed

This article examines formulation and fabrication methods for delivering cannabinoids through oral mucosal routes, relevant to clinicians seeking alternative administration techniques beyond smoking or standard ingestion.

Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML

**Summary:** Study demonstrates CBD-dominant cannabis products effectively reduce anxiety symptoms, providing clinicians with evidence-based data for therapeutic recommendations and patient treatment planning.

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

A clinical trial demonstrates cannabis extracts’ efficacy in reducing myofascial pain, providing clinicians evidence-based data for treating this prevalent musculoskeletal condition.

As a Medical Cannabis Patient, I’m Watching This Supreme Court Case Closely

This article discusses a Supreme Court case relevant to medical cannabis patients and clinicians regarding legal protections or regulatory frameworks affecting medical cannabis practice and patient access.

The Week in Weed: March 2026 | Seyfarth Shaw LLP – JDSupra

This article covers cannabis regulatory and legal developments from March 2026, providing clinicians with updates on compliance requirements and policy changes affecting clinical practice and patient care.

Marijuana gummies sold in Ohio recalled. Why, where they were sold – The Columbus Dispatch

Marijuana gummies sold in Ohio were recalled, requiring clinicians to inform patients about potential product safety issues and advise them to verify their cannabis product sources and batch numbers.

New Group Launches Ahead of Medicare CBD Pilots – Cannabis Wire

A new organization is forming to prepare for upcoming Medicare pilot programs testing cannabidiol, which could expand clinical access and insurance coverage for CBD-based treatments.

Marijuana Status Based Prohibition Tag Archives – Powers Law Firm PA

This article covers legal prohibition status and regulatory frameworks for marijuana, which matters to cannabis clinicians because understanding jurisdictional legal restrictions directly affects treatment recommendations and patient counseling.

Louisiana lawmaker files bill to legalize recreational marijuana through licensed dispensaries

A Louisiana legislator proposed legalizing recreational marijuana sales via regulated dispensaries, directly impacting clinical cannabis practice through potential changes to prescribing frameworks and patient access pathways.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

A Georgia mother’s homemade medical cannabis formulation has gained commercial distribution through state dispensaries, demonstrating patient-developed preparations entering regulated markets.

Virginia adult-use sales bills pass both chambers, head to conference committee! – Blog

Virginia’s adult-use cannabis sales legislation passed both legislative chambers and requires conference committee reconciliation before potentially becoming law, affecting regulated market implementation and clinical practice standards.

Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown

This article examines medical marijuana’s therapeutic benefits and drawbacks while Tennessee’s regulatory status remains uncertain, directly affecting clinical practice and patient access decisions.

2026 Utah legislature on cannabis, psychedelics and kratom – Fox 13

The 2026 Utah legislature will address cannabis, psychedelics, and kratom regulation—directly impacting clinicians’ ability to recommend these substances and patients’ legal access to treatment options.

Georgia bill could limit probable cause for smell of marijuana, cannabis, or hemp – YouTube

Georgia legislation may restrict police use of marijuana/cannabis/hemp odor as probable cause for searches, potentially affecting legal protections for patients and clinicians in the state.

Prescription Cannabidiol CBD Oil Market to Hit US$ 190.9 Billion by 2032 at 23.48% CAGR

Market analysis projects prescription CBD oil revenues will reach $190.9 billion by 2032, reflecting significant growth that clinicians should monitor for treatment accessibility, product availability, and clinical evidence development.

TPS Cannabis News – StratCann

InMed Pharmaceuticals Shifts Focus to Therapeutic Programs, Ends BayMedica’s Non …

InMed Pharmaceuticals discontinued its non-therapeutic cannabis operations at BayMedica, redirecting resources toward clinical pharmaceutical development—relevant to clinicians tracking cannabinoid-based therapeutic commercialization pathways.

Pediatricians warn about cannabis use disorder, kids’ easy access to the drug – YouTube

Pediatricians highlight cannabis use disorder in children and accessibility concerns, which matters to cannabis clinicians treating youth and developing age-appropriate clinical protocols.

West Virginia House Passes Bill To Allocate Medical Marijuana Revenue, With Some …

West Virginia legislators advanced a bill directing medical marijuana tax revenue allocation, establishing financial framework implementation relevant to clinical program operations and patient access infrastructure.

The science behind roadside THC testing and diving into SGI’s zero-tolerance policy – Global News

This article examines roadside THC detection methods and Saskatchewan Government Insurance’s zero-tolerance impaired driving policy, relevant to clinicians assessing patient safety and legal implications of cannabis use.

‘Pot for Potholes Act’ aims to legalize marijuana in Tennessee and distribute taxes to repair …

Tennessee’s proposed “Pot for Potholes Act” would legalize marijuana and dedicate tax revenue to infrastructure, requiring clinicians to understand potential changes to prescribing regulations and patient access.

One of Colorado’s Largest Dispensary Chains Agrees to Buyout – Denver Westword

One of Colorado’s largest cannabis dispensary chains is being acquired, which may affect patient access, pricing, and product availability in the state’s regulated market.

Cannabis legalization driving increases in marijuana use among US adults with historically … – MSN

**Legalization correlates with increased marijuana consumption among US adults from historically underrepresented populations, requiring clinicians to understand evolving epidemiology and access patterns.**

What’s Really Happening With Cannabis ETF MSOS? – The Dales Report

To help you, please share the article text or key details about what MSOS performance trends, regulatory changes, or market factors it discusses.

Scientists are raising new concerns about marijuana use in teens – KPBS

Adolescent cannabis use is associated with elevated psychiatric risks including psychosis, depression, and anxiety, making age-specific patient assessment and counseling essential for clinical practice.

Can the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure

Prenatal cannabis exposure may affect fetal neurodevelopment through placental disruption, with placental biomarkers potentially identifying early schizophrenia risk in exposed pregnancies.

These items reflect a maturing cannabis market characterized by expanding medical access, growing clinical evidence supporting specific cannabinoid applications, and ongoing regulatory fragmentation across jurisdictions. The clinical evidence highlighted suggests CBD and cannabinoid extracts may have legitimate therapeutic roles in conditions like anxiety and myofascial pain, though formulation delivery methods and product standardization remain significant challenges. Concurrently, regulatory inconsistency around THC beverages and edible potency caps demonstrates that policy development has not kept pace with product innovation or the emerging clinical literature.

FAQ

This News item was assembled from structured source metadata and pipeline scoring.